2Bardwick PA, Zvaifler NJ, Gill GN, et al. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes:the POEMS syndrome : report on two cases and a review of the literature[J]. Medicine,1980,59 (4) :311-322.
3Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome : definitions and long-term outcome[ J ]. Blood,2003,101 (7) :2496-2506.
4Nakanishi T, Sobue I,Toyokura Y, et al. The Crow-Fukase syndrome : a study of 102 cases in Japan[J]. Neurology,1984,34(6) :712-720.
5Crow RS. Peripheral neuritis in myelomatosis[ J ]. Brit Med J, 1956,2 (4996) :802-804.
6Koga H, Tokunaga Y, Hisamoto T, et al. Ratio of serum vascular endothelial growth factor to platelet count correlates with disease activity in a patient with POEMS syndrome[ J ]. Eur J Intern Med,2002,13 ( 1 ) : 70-74.
7Hashiguchi RK, Belec L, Soubrier M, et al. Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome [ J ]. Blood, 1996,87 (4) : 1458 -1465.
8Scarlato M, Previtali SC, Carpo M, et al. Polyneuropathy in POEMS syndrome : role of angiogenic factors in the pathogenesis [ J ]. Brain, 2005,128(8) :1911-1920.
9Dispenzieri A, Moreno-Aspitia A, Suarez GA, et al. Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome and a review of the literature[ J ]. Blood ,2004,104 (10) :3400-3407.
10Sinisalo M, Hietaharju A, Sauranen J, et al. Thalidomide in POEMS syndrome : case report [ J ]. Am J Hematol,2004,76 : 66 -68.
